We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$82.7B
1-Year Est. Return
28.53%
This Fund
S&P 500
This Quarter
Est. Return
+8.07%
1 Year Est. Return
+28.53%
3 Year Est. Return
+81.04%
5 Year Est. Return
+81.98%
10 Year Est. Return
–
AUM
$61.7B
AUM Growth
+$5.59B
(+10%)
Cap. Flow
+$1.71B
Cap. Flow
% of AUM
2.78%
Top 10 Holdings %
Top 10 Hldgs %
25.83%
Holding
2,898
New
272
Increased
1,366
Reduced
967
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$141M |
| 2 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$99.4M |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$81.6M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$70.4M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$69.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$61.6M |
| 2 |
Procter & Gamble
PG
|
+$60.8M |
| 3 |
Vanguard Total Bond Market
BND
|
+$58.8M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$38.5M |
| 5 |
Innovator US Equity Power Buffer ETF December
PDEC
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.63% |
| 2 | Financials | 8.07% |
| 3 | Healthcare | 5.98% |
| 4 | Industrials | 5.03% |
| 5 | Consumer Discretionary | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
2701
DELISTED
Esperion Therapeutics
ESPR
| $47.9K | ﹤0.01% |
+18,068
| New | +$34.9K |
|
2702
Clear Channel Outdoor Holdings
CCO
$1.19B
| $47.8K | ﹤0.01% |
+30,261
| New | +$37.7K |
|
2703
Standard BioTools
LAB
$281M
| $47.6K | ﹤0.01% |
36,588
-913
| -2% | -$1.2K |
|
2704
OmniAb
OABI
$496M
| $47.3K | ﹤0.01% |
29,562
+6,950
| +31% | +$12.7K |
|
2705
Beyond Meat
BYND
$6.9B
| $44.5K | ﹤0.01% |
784
-48
| -6% | -$4.24K |
|
2706
Energy Vault
NRGV
$681M
| $43.1K | ﹤0.01% |
14,497
-4,463
| -24% | -$7.32K |
|
2707
Rocket Pharmaceuticals
RCKT
$381M
| $43K | ﹤0.01% |
+13,187
| New | +$41.5K |
|
2708
DocGo
DCGO
$65.6M
| $42.7K | ﹤0.01% |
31,429
+7,803
| +33% | +$11.8K |
|
|
LPRO
2709
DELISTED
Open Lending Corp
LPRO
| $41.1K | ﹤0.01% |
19,495
-3,149
| -14% | -$7.12K |
|
2710
Strive Inc
ASST
$1.05B
| $38.5K | ﹤0.01% |
+771
| New | +$73.3K |
|
|
BORR
2711
Borr Drilling
BORR
$1.36B
| $33.3K | ﹤0.01% |
+12,376
| New | +$30.8K |
|
2712
Sabre
SABR
$904M
| $32.9K | ﹤0.01% |
17,963
-12,499
| -41% | -$29.5K |
|
|
LFT
2713
Lument Finance Trust
LFT
$34.3M
| $32K | ﹤0.01% |
15,831
-2,358
| -13% | -$5.18K |
|
2714
Lisata Therapeutics
LSTA
$10.3M
| $30.7K | ﹤0.01% |
12,183
| – | – |
|
2715
Westwater Resources
WWR
$72.2M
| $28.5K | ﹤0.01% |
+30,001
| New | +$22.5K |
|
2716
ImmunityBio
IBRX
$7.95B
| $28.2K | ﹤0.01% |
+11,468
| New | +$29.5K |
|
|
OKYO
2717
OKYO Pharma
OKYO
$79.8M
| $25.6K | ﹤0.01% |
12,812
| – | – |
|
2718
Geron
GERN
$937M
| $25.3K | ﹤0.01% |
18,485
-2,439
| -12% | -$3.25K |
|
2719
CPI Aerostructures
CVU
$77.5M
| $25.2K | ﹤0.01% |
10,000
| – | – |
|
2720
Kosmos Energy
KOS
$1.52B
| $24K | ﹤0.01% |
14,443
-21,047
| -59% | -$39.4K |
|
|
AKTX
2721
Akari Therapeutics
AKTX
$13.5M
| $23.9K | ﹤0.01% |
591
| – | – |
|
|
ORGN
2722
DELISTED
Origin Materials
ORGN
| $22.7K | ﹤0.01% |
1,459
| – | – |
|
2723
Coherus Oncology
CHRS
$184M
| $22.5K | ﹤0.01% |
13,746
+3,186
| +30% | +$3.54K |
|
2724
Innoviz Technologies
INVZ
$107M
| $22.1K | ﹤0.01% |
10,837
-706
| -6% | -$1.2K |
|
2725
Fractyl Health
GUTS
$109M
| $21.6K | ﹤0.01% |
13,566
-4,920
| -27% | -$6.38K |
|
Similar funds
Cerity Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Cerity Partners held 2,898 positions worth $61.7B, up 10% from $56.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cerity Partners's Q3 2025 filing shows 272 new, 1,366 increased, 967 reduced and 159 closed positions. Its largest new stake was Arista Networks: 306,282 shares worth $43.2M. The largest sale was iShares 0-3 Month Treasury Bond ETF, an estimated $61.6M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Cerity Partners's largest Q3 2025 buy was Arista Networks: 306,282 shares worth $43.2M.
- Cerity Partners added most to NVIDIA in Q3 2025, an estimated $141M increase.
- Cerity Partners's biggest Q3 2025 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $61.6M.
- Cerity Partners fully exited Ansys in Q3 2025, selling an estimated $8.12M.
- Cerity Partners's ten largest holdings make up 26% of its $61.7B portfolio in Q3 2025.
- Cerity Partners opened 272 new positions and closed 159 in Q3 2025.
- Cerity Partners's portfolio value rose 10% quarter-over-quarter to $61.7B.
Based on Cerity Partners's 13F filing for Q3 2025, filed 22 Oct 2025.